UDI: Value Beyond Compliance

By AHRMM

In this informational session, Karen Conway discusses her research with the FDA on value and the UDI. Mike Schiller joins the conversation by adding the actions AHRMM is taking with the Learning UDI Community to identify adoption practices and move beyond compliance.

Related Resources

Letter/Comment
The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo
Issue Brief
Alarm Safety Management
This learning lab covers alarm safety management in the health care supply chain field.
Toolkits/Methodology
Guidance for Writing Comments
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision…
Advisory
Medical Device Tax Next Steps
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.
Advisory
Statement on Pricing Transparency
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<
Toolkits/Methodology
Strategic Marketplace Initiative (SMI) Resources for Supply Chain
The Strategic Marketplace Initiative (SMI) is a consortium of healthcare supply ch